Range Low Price High Price Comment
30 days $68.59 $84.57 Wednesday, 27th Mar 2024 AXSM stock ended at $79.17. This is 3.19% more than the trading day before Tuesday, 26th Mar 2024. During the day the stock fluctuated 6.33% from a day low at $74.53 to a day high of $79.25.
90 days $68.59 $98.40
52 weeks $55.03 $98.40

Historical Axsome Therapeutics prices

Date Open High Low Close Volume
2024-01-16 $85.00 $85.84 $83.66 $84.95 501 895
2024-01-12 $87.58 $88.00 $84.72 $85.21 530 817
2024-01-11 $88.01 $88.64 $85.88 $86.35 585 871
2024-01-10 $90.40 $92.19 $88.10 $89.20 736 702
2024-01-09 $88.14 $90.70 $87.33 $90.43 656 162
2024-01-08 $83.74 $88.99 $83.00 $88.94 942 812
2024-01-05 $81.07 $82.67 $79.63 $82.31 821 604
2024-01-04 $78.07 $85.76 $77.62 $81.99 1 534 936
2024-01-03 $76.95 $77.82 $75.41 $76.09 415 003
2024-01-02 $78.60 $80.95 $76.00 $77.06 648 378
2023-12-29 $79.53 $80.05 $78.40 $79.59 475 191
2023-12-28 $83.66 $84.24 $79.15 $79.62 493 821
2023-12-27 $79.53 $83.80 $79.14 $83.61 1 189 975
2023-12-26 $77.75 $79.47 $77.51 $79.37 511 698
2023-12-22 $74.28 $78.39 $73.24 $76.82 1 186 879
2023-12-21 $71.08 $73.14 $70.97 $72.48 414 601
2023-12-20 $73.51 $73.51 $70.23 $70.55 468 661
2023-12-19 $73.88 $74.89 $72.57 $73.85 398 759
2023-12-18 $72.44 $74.00 $71.03 $73.20 340 773
2023-12-15 $73.64 $74.39 $71.80 $72.99 637 007
2023-12-14 $76.05 $76.05 $71.50 $73.27 884 643
2023-12-13 $71.74 $74.52 $70.55 $74.44 730 775
2023-12-12 $70.00 $70.77 $69.07 $70.16 364 937
2023-12-11 $70.00 $70.17 $67.84 $69.65 402 079
2023-12-08 $70.97 $72.78 $69.49 $70.18 655 592
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT